Assignee
AROCELL AB
SE·3 granted patents·5 pending applications·3 citations·filing 2009–2022
Top patents by PatentIndex Score
8 records- 0177US10551385B2Predicting cancer progressionAROCELL AB·Filed 2016·Granted Feb 4, 2020·2 cites·5 claims
- 0268US10100128B2Monoclonal anti-TK1 antibodiesAROCELL AB·Filed 2014·Granted Oct 16, 2018·1 cites·14 claims
- 0365US11959919B2Predicting cancer progressionAROCELL AB·Filed 2019·Granted Apr 16, 2024·0 cites·8 claims
- 0456US2019002587A1Monoclonal anti-tk1 antibodiesAROCELL AB·Filed 2018·Application pending·0 cites
- 0554US2024288432A1Predicting cancer relapseAROCELL AB·Filed 2022·Application pending·0 cites
- 0652US2010311081A1Predicting cancer progressionAROCELL AB·Filed 2009·Application pending·0 cites
- 0747US2022221456A1Respiratory infection detection and classificationAROCELL AB·Filed 2020·Application pending·0 cites
- 0845US2023070840A1Predicting patient survivalAROCELL AB·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →